Inventor · disambiguated record
Steven Prestrelski
Also filed as: PRESTRELSKI STEVEN · PRESTRELSKI STEVEN J · PRESTRELSKI STEVEN JOSEPH
34 granted patents·28 pending applications·1,717 citations·filing 1994–2024
98Inventor score
Files withXERIS PHARMACEUTICALS INC31ALZA CORP10PRESTRELSKI STEVEN5POWDERJECT RES LTD3AMYLIN PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
62 records- 0197US6235712B1Non-aqueous polar aprotic peptide formulationsALZA CORP·Filed 2000·Granted May 22, 2001·113 cites·19 claims
- 0296US8110209B2Intracutaneous injectionPRESTRELSKI STEVEN·Filed 2003·Granted Feb 7, 2012·106 cites·19 claims
- 0396US6124261ANon-aqueous polar aprotic peptide formulationsALZA CORP·Filed 1999·Granted Sep 26, 2000·146 cites·41 claims
- 0496US5972369ADiffusional implantable delivery systemALZA CORP·Filed 1998·Granted Oct 26, 1999·260 cites·31 claims
- 0596US5932547ANon-aqueous polar aprotic peptide formulationsALZA CORP·Filed 1997·Granted Aug 3, 1999·151 cites·34 claims
- 0695US7022313B2Hydrogel particle formulationPOWDERJECT RES LTD·Filed 2001·Granted Apr 4, 2006·81 cites·15 claims
- 0795US5580856AFormulation of a reconstituted protein, and method and kit for the production thereofFiled 1994·Granted Dec 3, 1996·369 cites·25 claims
- 0894US6730328B2Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivityFiled 2001·Granted May 4, 2004·131 cites·11 claims
- 0993US9649364B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted May 16, 2017·12 cites·16 claims
- 1092US9642894B2Compositions for rapidly treating severe hypoglycemiaXERIS PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·5 cites·2 claims
- 1192US7229645B2Spray freeze-dried compositionsPOWDERJECT RES LTD·Filed 2002·Granted Jun 12, 2007·35 cites·18 claims
- 1291US10485850B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 26, 2019·8 cites·12 claims
- 1391US6264990B1Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity.ALZA CORP·Filed 1997·Granted Jul 24, 2001·115 cites·12 claims
- 1490US9339545B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·13 cites·27 claims
- 1589US11020403B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2018·Granted Jun 1, 2021·4 cites·22 claims
- 1688US9125805B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2013·Granted Sep 8, 2015·12 cites·8 claims
- 1787US9138479B2Formulations for the treatment of diabetesXERIS PHARMACEUTICALS INC·Filed 2012·Granted Sep 22, 2015·11 cites·34 claims
- 1886US9018162B2Methods for rapidly treating severe hypoglycemiaXERIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 28, 2015·3 cites·17 claims
- 1986US2024207365A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2086US2024342249A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2184US11446310B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·1 cites·21 claims
- 2283US9302010B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 5, 2016·5 cites·19 claims
- 2383US8697644B2Stable formulations for parenteral injection of peptide drugsPRESTRELSKI STEVEN·Filed 2012·Granted Apr 15, 2014·6 cites·14 claims
- 2483US2024041984A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2581US5981489ANon-aqueous protic peptide formulationsALZA CORP·Filed 1997·Granted Nov 9, 1999·48 cites·63 claims
- 2679US11964003B2Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·1 cites·47 claims
- 2777US6068850AAqueous formulations of peptidesALZA CORP·Filed 1999·Granted May 30, 2000·33 cites·30 claims
- 2876US11590205B2Methods for producing stable therapeutic glucagon formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 28, 2023·1 cites·8 claims
- 2975US8790679B2Intracutaneous paste compositionPRESTRELSKI STEVEN·Filed 2010·Granted Jul 29, 2014·6 cites·17 claims
- 3073US2021315961A1Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3170US2024148680A1Stable levothyroxine compositions in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3269US9314424B2Pastes for injection of a therapeutic agentXERIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 19, 2016·3 cites·20 claims
- 3368US2015111824A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 3467US5916582AAqueous formulations of peptidesALZA CORP·Filed 1997·Granted Jun 29, 1999·19 cites·12 claims
- 3567US2024238381A1Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3667US2020215162A1Methods for Producing Stable Therapeutic Formulations in Aprotic Polar SolventsXERIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3766US11833157B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·0 cites·25 claims
- 3866US2008038356A1Spray freeze-dried compositionsMAA YUH-FUN·Filed 2007·Application pending·0 cites
- 3964US10987399B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2016·Granted Apr 27, 2021·0 cites·16 claims
- 4064US2008200383A1Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4163US9295724B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·0 cites·27 claims
- 4262US9687527B2Stable glucagon formulations for the treatment of hypoglycemiaPRESTRELSKI STEVEN·Filed 2014·Granted Jun 27, 2017·0 cites·13 claims
- 4362US6066619ANon-aqueous protic peptide formulationsALZA CORP·Filed 1999·Granted May 23, 2000·19 cites·13 claims
- 4462US2005214227A1Microparticle formulations for sustained-release of bioactive compoundsPOWDERJECT RES LTD·Filed 2004·Application pending·0 cites
- 4562US2024148678A1Sustained release injectable therapeutic formulations using aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4661US2004151779A1Stable flowable protien and nucleic acd formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivityALZA CORP·Filed 2004·Application pending·0 cites
- 4760US10765683B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 8, 2020·0 cites·13 claims
- 4858US2023085357A1Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereofXERIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4957US2005266021A1Powder compositionsPOWDERJECT VACCINES INC·Filed 2005·Application pending·0 cites
- 5055US2004213798A1Spray-dried alum compositionsPOWDERJECT VACCINES INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven Prestrelski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →